MGRC and Twistcode Technologies collaborate to develop advanced bioinformatics platform


Malaysian Genomics Resource Centre Bhd executive chairman Azri Azerai

KUALA LUMPUR: Malaysian Genomics Resource Centre Bhd’s (MGRC) wholly-owned subsidiary MGRC Therapeutics Sdn Bhd (MGRCT) has entered a memorandum of understanding (MoU) with Twistcode Technologies Sdn Bhd.

In a statement, MGRC said the collaboration will focus on the bioinformatics enhanced-accelerated services terminal (B.E.A.S.T), a cutting-edge platform designed to revolutionise bioinformatics services across Malaysia and the Middle East.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
MGRC , Twistcode Technologies , MoU , Azri Azerai

Next In Business News

Bursa Malaysia remains lower at midday, KLCI down 0.54%
MUI Properties to buy Ijok land for RM605mil
Geohan sets sights on Singapore to drive regional growth
DRB-Hicom shares up on revised US$110.62mil purchase price for Spirit MY
AirAsia X eyes second-tier cities and broader Europe-Central Asia connectivity next year
Japan's Nikkei skids in subdued Asia as bets of rate hike grow
Oil prices head for 2% weekly gain as Fed hopes boost market, Venezuela tensions loom
Ringgit opens stronger at RM4.10 vs greenback
Subdued trading on Bursa continues as traders await Fed rate decision
Trading ideas: DRB-Hicom, Al-Aqar, Haily, Pharmaniaga, Gagasan Nadi, Paragon, Orkim, BMS, VS Industry, APB, Destini, MSC, Only World, HB Global, Jetson

Others Also Read